Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib. The aim of this study was to evaluate whether concomitant treatment with conventional synthetic disease‐modifying antirheumatic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L., Curtis, Jeffrey R., Lindsey, Stephen, Tanaka, Yoshiya, Yamaoka, Kunihiro, Valdez, Hernan, Hirose, Tomohiro, Nduaka, Chudy I., Wang, Lisy, Mendelsohn, Alan M., Fan, Haiyun, Chen, Connie, Bananis, Eustratios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656820/
https://www.ncbi.nlm.nih.gov/pubmed/28845604
http://dx.doi.org/10.1002/art.40189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656820/
https://www.ncbi.nlm.nih.gov/pubmed/28845604
http://dx.doi.org/10.1002/art.40189

Ejemplares similares